You have 9 free searches left this month | to do more

pirtobrutinib

Pirtobrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Mantle-Cell, and other conditions. Pirtobrutinib is being actively studied in 8 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Loxo Oncology, Inc.Memorial Sloan Kettering Cancer Center
Eli Lilly and CompanyNagoya Medical Center
M.D. Anderson Cancer CenterFlorida Cancer Specialists
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
Active, not recruiting
  • Healthy
  • Springfield, Missouri
  • +1 more
2022-03-22
Mar 22, 2022
M
Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-04-07
Apr 7, 2022
L
Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • (no location specified)
2022-02-15
Feb 15, 2022
L
Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Pirtobrutinib
  • Stanford, California
  • +19 more
2022-04-05
Apr 5, 2022
L
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Pirtobrutinib
  • +2 more
  • Fort Myers, Florida
  • +26 more
2021-11-16
Nov 16, 2021
L
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Pirtobrutinib
  • +2 more
  • Los Angeles, California
  • +40 more
2022-03-11
Mar 11, 2022
E
Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Miami, Florida
  • +4 more
2022-03-07
Mar 7, 2022
L
Recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Pirtobrutinib
  • +2 more
  • Scottsdale, Arizona
  • +55 more
2022-01-12
Jan 12, 2022
L
Recruiting
  • Lymphoma, Mantle-Cell
  • Pirtobrutinib
  • +3 more
  • Phoenix, Arizona
  • +147 more
2022-03-04
Mar 4, 2022